392 related articles for article (PubMed ID: 30040954)
21. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
[TBL] [Abstract][Full Text] [Related]
22. Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes.
Gravning J; Ahmed MS; Qvigstad E; Krobert K; Edvardsen T; Moe IT; Hagelin EM; Sagave J; Valen G; Levy FO; Osnes JB; Skomedal T; Attramadal H
Mol Pharmacol; 2013 Sep; 84(3):372-83. PubMed ID: 23778361
[TBL] [Abstract][Full Text] [Related]
23. CCN2 in Skin Fibrosis.
Leask A
Methods Mol Biol; 2017; 1489():417-421. PubMed ID: 27734393
[TBL] [Abstract][Full Text] [Related]
24. Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
Rebolledo DL; González D; Faundez-Contreras J; Contreras O; Vio CP; Murphy-Ullrich JE; Lipson KE; Brandan E
Matrix Biol; 2019 Sep; 82():20-37. PubMed ID: 30716392
[TBL] [Abstract][Full Text] [Related]
25. Stretch-induced upregulation of connective tissue growth factor in rabbit cardiomyocytes.
Blaauw E; Lorenzen-Schmidt I; Babiker FA; Munts C; Prinzen FW; Snoeckx LH; van Bilsen M; van der Vusse GJ; van Nieuwenhoven FA
J Cardiovasc Transl Res; 2013 Oct; 6(5):861-9. PubMed ID: 23835778
[TBL] [Abstract][Full Text] [Related]
26. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
[TBL] [Abstract][Full Text] [Related]
27. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
Frangogiannis NG
Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
[TBL] [Abstract][Full Text] [Related]
28. Studying the CCN Proteins in Fibrosis.
Hutchenreuther J; Leask A; Thompson K
Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
[TBL] [Abstract][Full Text] [Related]
29. Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation.
Adam O; Lavall D; Theobald K; Hohl M; Grube M; Ameling S; Sussman MA; Rosenkranz S; Kroemer HK; Schäfers HJ; Böhm M; Laufs U
J Am Coll Cardiol; 2010 Feb; 55(5):469-80. PubMed ID: 20117462
[TBL] [Abstract][Full Text] [Related]
30. Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis.
Kantarci A; Black SA; Xydas CE; Murawel P; Uchida Y; Yucekal-Tuncer B; Atilla G; Emingil G; Uzel MI; Lee A; Firatli E; Sheff M; Hasturk H; Van Dyke TE; Trackman PC
J Pathol; 2006 Sep; 210(1):59-66. PubMed ID: 16841303
[TBL] [Abstract][Full Text] [Related]
31. Loss of PTEN expression by mouse fibroblasts results in lung fibrosis through a CCN2-dependent mechanism.
Parapuram SK; Thompson K; Tsang M; Hutchenreuther J; Bekking C; Liu S; Leask A
Matrix Biol; 2015 Apr; 43():35-41. PubMed ID: 25644104
[TBL] [Abstract][Full Text] [Related]
32. Genetic manipulation of CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle.
Petrosino JM; Leask A; Accornero F
FASEB J; 2019 Feb; 33(2):2047-2057. PubMed ID: 30216109
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure.
van Almen GC; Verhesen W; van Leeuwen RE; van de Vrie M; Eurlings C; Schellings MW; Swinnen M; Cleutjens JP; van Zandvoort MA; Heymans S; Schroen B
Aging Cell; 2011 Oct; 10(5):769-79. PubMed ID: 21501375
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
35. Polycystin-1 mitigates damage and regulates CTGF expression through AKT activation during cardiac ischemia/reperfusion.
Aránguiz P; Romero P; Vásquez F; Flores-Vergara R; Aravena D; Sánchez G; González M; Olmedo I; Pedrozo Z
Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165986. PubMed ID: 33065236
[TBL] [Abstract][Full Text] [Related]
36. Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis.
Riquelme-Guzmán C; Contreras O; Brandan E
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C415-C427. PubMed ID: 29351412
[TBL] [Abstract][Full Text] [Related]
37. A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis.
Shiwen X; Stratton R; Nikitorowicz-Buniak J; Ahmed-Abdi B; Ponticos M; Denton C; Abraham D; Takahashi A; Suki B; Layne MD; Lafyatis R; Smith BD
PLoS One; 2015; 10(5):e0126015. PubMed ID: 25955164
[TBL] [Abstract][Full Text] [Related]
38. Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor.
Wang X; McLennan SV; Allen TJ; Tsoutsman T; Semsarian C; Twigg SM
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1490-500. PubMed ID: 19625611
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF/MicroRNA-133a Axis.
Angelini A; Li Z; Mericskay M; Decaux JF
PLoS One; 2015; 10(10):e0139858. PubMed ID: 26440278
[TBL] [Abstract][Full Text] [Related]
40. ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene.
Chatzifrangkeskou M; Le Dour C; Wu W; Morrow JP; Joseph LC; Beuvin M; Sera F; Homma S; Vignier N; Mougenot N; Bonne G; Lipson KE; Worman HJ; Muchir A
Hum Mol Genet; 2016 Jun; 25(11):2220-2233. PubMed ID: 27131347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
